Financhill
Back

Ocular Therapeutix Quote, Financials, Valuation and Earnings

Ocular Therapeutix Price Quote

$5.81
-0.36 (-5.83%)
(Updated: May 6, 2024 at 6:55 PM ET)

Ocular Therapeutix Key Stats

Buy
60
Ocular Therapeutix (OCUL) is a Buy

Day range:
$6.03 - $6.40
52-week range:
$2.00 - $11.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.73
P/B ratio:
10.06%

Volume:
4.6M
Avg. volume:
2.5M
1-year change:
-0.32%
Market cap:
$917M
Revenue:
$58.4M
EPS:
$-1.25

How Much Does Ocular Therapeutix Make?

Is Ocular Therapeutix Growing As A Company?

  • What Is Ocular Therapeutix's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ocular Therapeutix Stock Price Performance

What Is Ocular Therapeutix 52-Week High & Low?

Ocular Therapeutix Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ocular Therapeutix?

  • How Much Debt Does Ocular Therapeutix Have?
    Total long term debt quarterly is $74.9M
  • How Much Cash Does Ocular Therapeutix Have?
    Cash and short term investments quarterly total is $195.8M
  • What Is Ocular Therapeutix’s Book Value Per Share?
    Book value per share is 0.79

Is Ocular Therapeutix Cash Flow Positive?

  • What Is OCUL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$70.2M
  • What Is Ocular Therapeutix’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $169.8M
  • What Is Ocular Therapeutix’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.1M

Ocular Therapeutix Return On Invested Capital

  • Is Management Doing A Good Job?
    OCUL return on invested capital is -87.75%
  • What Is Ocular Therapeutix Return On Assets?
    ROA measures how assets are converting to revenues and is -49.54%
  • What Is OCUL Return On Equity?
    ROE is a measure of profitability and is -274.31%

Ocular Therapeutix Earnings Date & Stock Price

Ocular Therapeutix Competitors

  • Who Are Ocular Therapeutix's Competitors?
    Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
    • Amgen Inc (AMGN)
    • Assertio Holdings Inc (ASRT)
    • CytomX Therapeutics Inc (CTMX)
    • EyePoint Pharmaceuticals Inc (EYPT)
    • Regeneron Pharmaceuticals Inc (REGN)

Ocular Therapeutix Dividend Yield

Data Unavailable

Ocular Therapeutix Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -60.92%
Revenue: 5.16% -5.77%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 15.50
Upside from Last Price: 151.22%

Major Shareholders

  • How many OCUL shares are owned by institutional investors?
    93.2M OCUL shares are owned by institutional investors
  • How many OCUL shares are owned by insiders?
    4.2M OCUL shares are owned by insiders